Latest Articles

Publication Date
Measles cases near 3,900 na­tionwide as Penn­syl­vania outbreak tops 1,000 and New York declares emergency - Spectrum News

Measles cases near 3,900 na­tionwide as Penn­syl­vania outbreak tops 1,000 and New York declares emergency Spectrum News

Published: Oct. 7, 2026, 2:15 p.m.
Duale at pains to explain why it took 48 hours to confirm Kenya's Ebola case - The Standard Media Group

Duale at pains to explain why it took 48 hours to confirm Kenya's Ebola case The Standard Media Group

Published: Oct. 7, 2026, 9:45 a.m.
Questions mount over Kenya's first Ebola case as Kalonzo demands transparency - www.standardmedia.co.ke

Questions mount over Kenya's first Ebola case as Kalonzo demands transparency www.standardmedia.co.ke

Published: Oct. 7, 2026, 9:08 a.m.
Bryan Johnson shifts focus from 'immortality' to disease treatment, says best anti-ageing therapy is filters - 디지털투데이

Bryan Johnson shifts focus from 'immortality' to disease treatment, says best anti-ageing therapy is filters 디지털투데이

Published: Oct. 7, 2026, 1:18 a.m.
Pathogenic Properties of Human Endometriotic Epithelial Cells Require Steroid Receptor Coactivator-2.

Commonly diagnosed in reproductive-age women, endometriosis is causally linked to subfertility, infertility, and chronic pelvic pain. Although theories exist on the etiopathogenesis of endometriosis, our understanding of its cellular and …

Published: Oct. 6, 2026, midnight
Do you have iron deficiency? New ferritin guidelines could increase diagnoses - NBC News

Do you have iron deficiency? New ferritin guidelines could increase diagnoses NBC News

Published: Oct. 5, 2026, 9:06 p.m.
Do you have iron deficiency? New ferritin guidelines could increase diagnoses - nbcnews.com

Do you have iron deficiency? New ferritin guidelines could increase diagnoses nbcnews.com

Published: Oct. 5, 2026, 9:06 p.m.
Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere - Fierce Biotech

Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere Fierce Biotech

Published: Oct. 5, 2026, 8:14 a.m.
Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere - fiercebiotech.com

Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere fiercebiotech.com

Published: Oct. 5, 2026, 8:14 a.m.
Realize Medical Showcases 3D Surgical Planning Use Case in Complex Gynecological Care - TipRanks

Realize Medical Showcases 3D Surgical Planning Use Case in Complex Gynecological Care TipRanks

Published: Oct. 5, 2026, 8:10 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!